CTRP13 attenuates the expression of LN and CAV-1 Induced by high glucose via CaMKK?/AMPK pathway in rLSECs.
Ontology highlight
ABSTRACT: OBJECTIVE:To investigate the effect and mechanism of CTRP13 on hepatic sinusoidal capillarization induced by high glucose in rat liver sinusoidal endothelial cells (rLSECs). RESULTS:CTRP13 was reduced in high glucose-treated rLSECs. High glucose increased LN and CAV-1 expression and inhibited CaMKK? and AMPK phosphorylation. CTRP13 overexpression protected rLSECs against high glucose-induced increase of LN and CAV-1 expression. Moreover, CTRP13 overexpression increased high glucose-induced inhibition of CaMKK? and AMPK activation in CTRP13-overexpressing rLSECs. Inhibition of CaMKK? and AMPK disturbed the protective effects of CTRP13 in high glucose-induced increase of LN and CAV-1. Hepatic steatosis was enhanced and basement membrane was thickened in liver of diabetic fatty liver rats. CONCLUSIONS:Our data identified the protective role of CTRP13 in hepatic sinusoidal capillarization induced by high glucose via activating CAMKK?/AMPK pathway. CTRP13 may be a potential target for screening and treating diabetic fatty liver. METHODS:Construct lentiviral CTRP13 overexpression vector and transfect rLSECs. Use STO-609 (a CaMKK? inhibitor) or Compound C (an AMPK inhibitor) to treat rLSECs. CTRP13, CaMKK?, AMPK, laminin (LN) and caveolin-1 (CAV-1) were detected by qRT-PCR and Western blotting. Establish rat model of diabetic fatty liver. Use immunohistochemistry, hematoxylin-eosin and silver staining to observe the histopathological features of liver.
SUBMITTER: Zhang Q
PROVIDER: S-EPMC7343496 | biostudies-literature | 2020 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA